Pentobarbital Produces Activation and Block of α1β2γ2S GABAA Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
Open Access
- 26 January 2009
- journal article
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 133 (2) , 171-188
Abstract
Millimolar concentrations of the barbiturate pentobarbital (PB) activate γ-aminobutyric acid (GABA) type A receptors (GABARs) and cause blockade reported by a paradoxical current increase or “tail” upon washout. To explore the mechanism of blockade, we investigated PB-triggered currents of recombinant α1β2γ2S GABARs in whole cells and outside-out membrane patches using rapid perfusion. Whole cell currents showed characteristic bell-shaped concentration dependence where high concentrations triggered tail currents with peak amplitudes similar to those during PB application. Tail current time courses could not be described by multi-exponential functions at high concentrations (≥3,000 μM). Deactivation time course decayed over seconds and was slowed by increasing PB concentration and application time. In contrast, macropatch tail currents manifested eightfold greater relative amplitude, were described by multi-exponential functions, and had millisecond rise times; deactivation occurred over fractions of seconds and was insensitive to PB concentration and application time. A parsimonious gating model was constructed that accounts for macropatch results (“patch” model). Lipophilic drug molecules migrate slowly through cells due to avid partitioning into lipophilic subcellular compartments. Inclusion of such a pharmacokinetic compartment into the patch model introduced a slow kinetic component in the extracellular exchange time course, thereby providing recapitulation of divergent whole cell results. GABA co-application potentiated PB blockade. Overall, the results indicate that block is produced by PB concentrations sixfold lower than for activation involving at least three inhibitory PB binding sites, suggest a role of blocked channels in GABA-triggered activity at therapeutic PB concentrations, and raise an important technical question regarding the effective rate of exchange during rapid perfusion of whole cells with PB.Keywords
This publication has 50 references indexed in Scilit:
- Barbiturate activation and modulation of GABAA receptors in neocortexNeuropharmacology, 2006
- Pentobarbital Differentially Modulates α1β3δ and α1β3γ2L GABAA Receptor CurrentsMolecular Pharmacology, 2004
- Defining the Propofol Binding Site Location on the GABAA ReceptorMolecular Pharmacology, 2004
- Structural elements near the C‐terminus are responsible for changes in nicotinic receptor gating kinetics following patch excisionThe Journal of Physiology, 2000
- Structural domains of the human GABAA receptor β3 subunit involved in the actions of pentobarbitalThe Journal of Physiology, 2000
- Activation and block of recombinant GABAA receptors by pentobarbitone: a single‐channel studyBritish Journal of Pharmacology, 2000
- Single channel properties of recombinant GABAA receptors containing γ2 or δ subtypes expressed with α1 and β3 subtypes in mouse L929 CellsThe Journal of Physiology, 1997
- Pharmacological and Physiological Characterization of Murine Homomeric β3 GABAA ReceptorsEuropean Journal of Neuroscience, 1997
- Desensitized states prolong GABAA channel responses to brief agonist pulsesNeuron, 1995
- GABAA Receptor ChannelsAnnual Review of Neuroscience, 1994